Peter Hotez, M.D., Ph.D

Molecular Virology and Microbiology Baylor College of Medicine, Houston, TX 
Hookworm, Neglected Tropical Diseases
"Peter Hotez"

President of the American Society for Tropical Medicine and Hygiene and Editor of PLoS Neglected Tropical Diseases.


Sign in to add mentor
Anthony Cerami grad student Baylor (Cell Biology Tree)
Gerhard Adam Schad grad student Penn
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pollet J, Strych U, Chen WH, et al. (2021) Receptor-binding domain recombinant protein RBD219-N1C1 on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Biorxiv : the Preprint Server For Biology
Pino M, Abid T, Pereira Ribeiro S, et al. (2021) A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Science Immunology. 6
Li G, Hoeweler L, Keegan B, et al. (2021) Potency testing for a recombinant protein vaccine early in clinical development: Lessons from the Tetraspanin 2 vaccine. Vaccine: X. 8: 100100
Naniche D, Hotez P, Bottazzi ME, et al. (2021) Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment. Eclinicalmedicine. 36: 100925
Batista C, Shoham S, Ergonul O, et al. (2021) Urgent needs to accelerate the race for COVID-19 therapeutics. Eclinicalmedicine. 36: 100911
Nanishi E, Borriello F, O'Meara TR, et al. (2021) Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity. Biorxiv : the Preprint Server For Biology
Lee J, Liu Z, Chen WH, et al. (2021) Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1. Applied Microbiology and Biotechnology
Bartsch SM, Wedlock PT, O'Shea KJ, et al. (2021) Lives and Costs Saved by Expanding and Expediting COVID-19 Vaccination. The Journal of Infectious Diseases
Pollet J, Chen WH, Versteeg L, et al. (2021) SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Human Vaccines & Immunotherapeutics. 1-11
Hoffman K, Liu Z, Hossain E, et al. (2021) Alterations to the Cardiac Metabolome Induced by Chronic Infection Relate to the Degree of Cardiac Pathology. Acs Infectious Diseases
See more...